Trial Profile
Postmarketing Surveillance of Tadalafil in Japanese Patients with Pulmonary Arterial Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 May 2018
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Therapeutic Use
- 15 Jun 2017 New trial record
- 01 May 2017 Results assessing safety (n=1676) and efficacy (n=1556), published in the Current Medical Research and Opinion